News

Cannabinoids are specific chemical compounds found in cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Research is increasingly su ...
The second half of 2025 could be much more favorable for stockpickers looking for the best small-cap stocks to buy.That might ...
In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Insmed, with a price target of $130.00. The company’s shares opened today at $109.83. Take advantage of ...
The postoperative pain management market is witnessing steady growth, driven by the rising number of surgical procedures globally and increasing awar ...
The risk for several adverse health outcomes, including PTSD, traumatic brain injury and anxiety, was heightened among active ...
Axsome Therapeutics reported record total product revenues of $150 million for the quarter, marking a 72% increase year-over-year and a 24% increase quarter-over-quarter. This impressive growth ...
Q2 2025 Earnings Call Transcript August 4, 2025 Axsome Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.92 ...